PS. I am not saying for a moment that PAA isn't on to...

PS. I am not saying for a moment that PAA isn't on to something. What l am thinking is if this very small trial reproduces earlier even smaller trials, then Elanco may br extremely interested. If all goes as hoped, an offer by Elanco may be very financially lucrative - by the current SP anyway. This presumably would give the multi national the opportunity to conduct much larger trials to prove up the initial data. This process would be expensive and time consuming but within their means. This would be the time to exit in my opinion unless you are happy to lock away capital for 5-10 years.